101 related articles for article (PubMed ID: 3810563)
1. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor.
Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
Thromb Res; 1986 Dec; 44(5):611-23. PubMed ID: 3810563
[TBL] [Abstract][Full Text] [Related]
2. Binding of 125I-labelled fibrin(ogen) fragments to platelets and to immunoprecipitated glycoprotein IIb-IIIa complex.
Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
Thromb Res; 1986 Jun; 42(5):645-59. PubMed ID: 2424122
[TBL] [Abstract][Full Text] [Related]
3. The N-DSK gamma-chain binds to immunoprecipitated GP IIb-IIIa.
Thorsen LI; Hessel B; Brosstad F; Gogstad G; Solum NO
Thromb Res; 1987 Aug; 47(3):315-21. PubMed ID: 3629559
[TBL] [Abstract][Full Text] [Related]
4. Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen.
Thorsen LI; Brosstad F; Solum NO; Stormorken H
Scand J Haematol; 1986 Feb; 36(2):203-10. PubMed ID: 3010440
[TBL] [Abstract][Full Text] [Related]
5. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the gamma chain platelet binding site on fibrinogen fragment D.
Kirschbaum NE; Mosesson MW; Amrani DL
Blood; 1992 May; 79(10):2643-8. PubMed ID: 1586714
[TBL] [Abstract][Full Text] [Related]
7. Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets.
Chen CS; Chou SH; Thiagarajan P
Biochemistry; 1988 Aug; 27(16):6121-6. PubMed ID: 3191112
[TBL] [Abstract][Full Text] [Related]
8. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa.
Ramsamooj P; Doellgast GJ; Hantgan RR
Thromb Res; 1990 Jun; 58(6):577-92. PubMed ID: 2385828
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation by fibrinogen polymers crosslinked across the E domain.
McManama G; Lindon JN; Kloczewiak M; Smith MA; Ware JA; Hawiger J; Merrill EW; Salzman EW
Blood; 1986 Aug; 68(2):363-71. PubMed ID: 3730607
[TBL] [Abstract][Full Text] [Related]
11. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
12. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
13. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
Oliver JA; Albrecht RM
Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
Agam G; Shohat O; Livne A
Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
17. The binding of fibrinogen to its platelet receptor.
Marguerie GA; Ardaillou N; Cherel G; Plow EF
J Biol Chem; 1982 Oct; 257(20):11872-5. PubMed ID: 6288701
[TBL] [Abstract][Full Text] [Related]
18. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
19. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism.
Hantgan RR
Biochim Biophys Acta; 1988 Jan; 968(1):24-35. PubMed ID: 2827786
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of the antiplatelet action of ajoene: direct interaction with the fibrinogen receptor.
Apitz-Castro R; Ledezma E; Escalante J; Jain MK
Biochem Biophys Res Commun; 1986 Nov; 141(1):145-50. PubMed ID: 3800991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
